Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

NCT03546829 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Early Stage Non-Small Cell Lung Cancer

Interventions

DRUG: Vancomycin
RADIATION: Precision hypofractionated radiation

Sponsor

Abramson Cancer Center at Penn Medicine